All the raised capital deducing the issuance cost will be used to supplement working capital and for expansion and merger and acquisition in the pharmaceutical circulation field.
The subscribers are required to not sell the shares within 36 months.
Most Popular Stories
- Toxic Algae Threatens Florida Fishing, Tourism
- Hispanic Groups Lead Voter Registration Drive
- Eva Mendes Gives Birth to a Baby Girl
- Plus-Size iPhones Live Up to The Hype
- Fed Signals It Will Keep Key Rate at Record Low
- FedEx Adding 50,000 Holiday Jobs
- Stocks Rise Before Fed Statement
- Occupy Wall Street Buys Up Student Debt
- Cool Features on Today's New iOS 8
- Kohl's Hiring 67,000 for the Holidays